Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
- PMID: 34000379
- DOI: 10.1016/j.cgh.2021.05.021
Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
Comment in
-
Reply.Clin Gastroenterol Hepatol. 2022 May;20(5):1191-1192. doi: 10.1016/j.cgh.2021.06.039. Epub 2021 Jul 2. Clin Gastroenterol Hepatol. 2022. PMID: 34217878 No abstract available.
Comment on
-
Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT.Clin Gastroenterol Hepatol. 2022 Feb;20(2):e228-e250. doi: 10.1016/j.cgh.2021.04.031. Epub 2021 Apr 22. Clin Gastroenterol Hepatol. 2022. PMID: 33895361 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
